Home/Filings/4/0001179110-18-008594
4//SEC Filing

Davidai Eli 4

Accession 0001179110-18-008594

CIK 0000826326other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 3:38 PM ET

Size

18.3 KB

Accession

0001179110-18-008594

Insider Transaction Report

Form 4
Period: 2018-06-05
Davidai Eli
Director
Transactions
  • Award

    Restricted Common Stock

    2018-02-28$2.00/sh+125,000$250,000125,000 total(indirect: By Zori Investment Limited)
  • Award

    Restricted Common Stock

    2015-04-02$5.00/sh+50,000$250,00050,000 total(indirect: By Zori Investment Limited)
  • Award

    Stock Options (right to buy)

    2016-01-15+104,50062,700 total
    Exercise: $1.51Exp: 2023-01-15Common Stock (104,500 underlying)
  • Award

    Stock Options (right to buy)

    2017-02-10+74,5750 total
    Exercise: $4.40Exp: 2027-02-10Common Stock (74,575 underlying)
  • Award

    Stock Options (right to buy)

    2018-05-14+65,00065,000 total
    Exercise: $2.35Exp: 2025-05-14Common Stock (260,000 underlying)
  • Award

    Stock Options (right to buy)

    2016-08-26+27,21027,210 total
    Exercise: $2.50Exp: 2023-08-26Common Stock (27,210 underlying)
Footnotes (9)
  • [F1]Twenty-five percent (25%) of the Stock Options granted shall vest upon the date of grant and each anniversary of the date of grant until the Stock Options have vested in full. The Options shall expire on May 14, 2025 the seventh anniversary of the date of grant. As of the date of grant on May 14, 2018, 65,000 options for shares of common stock were fully vested and exercisable.
  • [F2]On May 14, 2018 Mr. Davidai was granted 260,000 shares of stock options where twenty-five percent (25%) of the Stock Options granted shall vest upon the date of grant and each anniversary of the date of grant until the Stock Options have vested in full. The Options shall expire on May 14, 2025 the seventh anniversary of the date of grant. As of May 14, 2018, the date of grant, 65,000 options for shares of common stock were fully vested and exercisable.
  • [F3]The Reporting Person is voluntarily early reporting beneficial ownership of the 260,000 Stock Options and only 25% or 65,000 stock options are vested on the date of grant and 75% will vest equally over the next three years on the anniversary date of the date of grant until the Stock Options have vested in full.
  • [F4]Twenty percent (20%) of the Stock Options granted vested upon the date of grant and each anniversary of the date of grant until the Stock Options have vested in full. The Options shall expire on January 15, 2023 the fifth anniversary of the date of grant. As of the date of this filing, 62,700 options for shares of common stock were fully vested and exercisable.
  • [F5]The entire 27,210 of Stock Options granted on August 26, 2016 were fully vested on the date of grant. The Stock Options will expire on August 26,2023.
  • [F6]The Reporting Person is voluntarily early reporting beneficial ownership of the 27,210 Stock Options vested on the date of grant.
  • [F7]The Reporting Person is voluntarily early reporting beneficial ownership of the 104,500 Stock Options and 60% or 62,700 of stock options have vested since the date of grant and 40% 0r 41,800 remain unvested. The stock options expire on January 15, 2023.
  • [F8]On February 10, 2017 Mr. Davidai was granted 74,575 shares of stock options that will vest on December 31, 2018. The stock options will expire on February 10, 2027.
  • [F9]The shares were purchased by Zori Investment Limited ("Zori"), a company controlled by the reporting person, pursuant to the terms and conditions of the Rights Offering Backstop Agreement (the "Backstop Agreement"), in the form of Exhibit 10.1 filed on January 11, 2018 with the U.S. Securities & Exchange Commission under Form S-1/A of the Issuer, Registration Statement 333-221967. The Backstop Agreement was executed by the reporting person on behalf of Zori on February 6, 2018. The issuer determined on February 24, 2018 to call for the purchase by Zori of 125,000 shares of Common Stock (the "Backstop Shares") at the purchase price of $2.00 per share, in accordance with the terms and conditions of the Backstop Agreement. All such Backstop Shares were duly purchased and issued by the Company to Zori on February 28, 2018.

Issuer

ARC Group Worldwide, Inc.

CIK 0000826326

Entity typeother

Related Parties

1
  • filerCIK 0001743194

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 3:38 PM ET
Size
18.3 KB